Table 1.

Clinical characteristics of the patients enrolled in this study

Age (years)	Day of cycle before GnRHa therapy	Stage of endometriosis
(a) Tissue for DIGE assay (n = 4)
33	15	IV
27	16	IV
27	18	IV
37	27	III
(b) Tissue for WB assay (n = 10)
33	10	IV
25	14	IV
32	17	IV
29	13	III
27	15	IV
26	13	III
29	15	IV
23	11	IV
39	9	IV
36	12	III

Stages of endometriosis according to the Revised American Fertility Society score (r-AFS). WB: Western blot analysis.